Some Cognitive Decline Has a Reversible Cause

The claim that medicines can impair thinking in older adults is not fringe. It is standard geriatric medicine, it has its own published criteria, and it is one of the first things a competent memory evaluation examines.

Before anything else, the presentation that does not wait. Confusion that develops over hours or days, with fluctuating alertness, is delirium rather than dementia, and it is a medical emergency — commonly caused by infection, dehydration, a new medication or withdrawal from one. Sudden weakness on one side, facial droop, difficulty speaking or a sudden severe headache require emergency care immediately.

And the standing rule matters more here than almost anywhere else: no medicine on any list should be stopped or reduced without the prescriber. Several drugs with cognitive effects are taken for serious conditions, and abrupt withdrawal of some of them causes seizures, rebound symptoms or worse.

With those set aside, the underlying medicine is well established. Drugs with anticholinergic activity block a neurotransmitter used throughout the brain in attention and memory, and the effect is dose-related, cumulative across several products, and largely reversible when the burden is reduced.

Sedatives of the benzodiazepine class and their newer relatives act differently but produce overlapping symptoms, particularly in older adults whose clearance is slower.

Professional bodies maintain explicit lists. Criteria published and updated by a geriatrics society name medications that are potentially inappropriate in older adults, with the reason and the strength of evidence for each, and clinicians and pharmacists use them routinely.

What none of this supports is the frightening version. A drug that impairs attention and memory is not causing Alzheimer's disease, and reversible impairment from medication is diagnosed by improvement after withdrawal rather than by a list.

The genuinely useful conclusion is procedural. Anyone concerned about memory should arrive at an appointment with a complete medication list, because that is the part of the evaluation most likely to yield something fixable.

What the Drugs Actually Do

The mechanism is specific, which is what makes the effect predictable rather than mysterious.

Acetylcholine is a neurotransmitter central to attention, learning and short-term memory. Drugs that block its receptors reduce those functions in proportion to how much blockade they produce.

Many medicines have anticholinergic activity as a side effect rather than a purpose: older antihistamines, some antidepressants, drugs for overactive bladder, several for nausea and vertigo, and some muscle relaxants.

Burden is cumulative. Scales exist that score individual drugs for anticholinergic activity and sum them across a person's list, and a total at or above a commonly used threshold of three is treated as clinically significant.

Peripheral effects arrive with the central ones and are easier to notice: dry mouth, constipation, blurred vision, urinary retention and a faster heart rate. Where several of those appear together, the burden is usually worth checking whatever the memory complaint.

Older adults are more affected for several reasons at once: reduced clearance, a more permeable blood-brain barrier, less cholinergic reserve, and more medicines taken simultaneously.

Sedative-hypnotics act on a different receptor system and produce daytime drowsiness, slowed processing and unsteadiness, with falls as the most serious consequence.

Timing of doses matters alongside the choice of drug. A sedating product taken in the evening can leave measurable impairment the following morning in an older person, and shifting the time or the formulation sometimes resolves the complaint without changing the medicine at all.

The distinguishing feature of all of this is reversibility. Where medication is the cause, function improves after the drug is reduced or replaced, usually over weeks — which is a test rather than a theory.

The Lists Clinicians Use

Explicit criteria exist precisely so that this is not a matter of individual opinion.

The criteria are organized by category: medicines to avoid in most older adults, medicines to avoid with specific conditions, medicines requiring caution, and interactions to avoid.

The evidence behind individual entries varies, and the criteria say so. Some rest on randomized data, others on observational studies and expert consensus, and the document grades each rather than presenting a flat list.

They are explicitly not a prohibition. Each entry states a rationale and a recommendation, and clinical judgment can properly override any of them for an individual.

Anticholinergic burden scales are separate instruments, several of them exist, and they disagree at the margins about which drugs score what — which is a reason to treat a total as a prompt rather than a verdict.

Prescribing cascades are the other pattern these reviews look for: a side effect of one drug treated with a second drug, whose own side effects are treated with a third. Identifying the original link frequently removes two medicines rather than one.

Over-the-counter products are where most of the unrecognized burden sits, because they are bought without a consultation and are frequently absent from the medication list a clinician sees.

The practical use of all of it is the same: a structured review that produces a decision for each item — continue, reduce, replace or stop, with a plan and a follow-up date.

What a Proper Workup Excludes First

Memory complaints have a standard evaluation, and reversible causes sit near the front of it.

Blood tests come first and are cheap: thyroid function and vitamin B12 are the classic reversible causes, alongside metabolic and kidney measures.

Depression is next and is frequently mistaken for dementia in older adults, producing poor concentration, slowed thinking and apparent memory failure that resolves with treatment.

Sleep disorders follow. Obstructive sleep apnea impairs attention and memory and is both common and treatable, and it is missed unless someone asks.

Pain and its treatment sit in the same conversation. Untreated pain impairs concentration and sleep, while some of the drugs used to treat it impair cognition directly, which makes it one of the harder trade-offs in the whole review.

Alcohol use is asked about explicitly, because it is a leading contributor and is under-reported in every age group.

Hearing and vision are checked in the same visit and are among the most under-appreciated contributors. Someone who cannot hear a question reliably performs poorly on a verbal memory test for reasons that have nothing to do with memory.

Imaging of the brain is used to exclude structural causes, and cognitive testing establishes a baseline against which any change after an intervention can be measured.

Only after that sequence does a diagnosis of a progressive dementia become appropriate, and the sequence exists because each earlier step can produce the same picture.

How Deprescribing Is Actually Done

Reducing a medication list is a clinical procedure with its own evidence base, not an act of subtraction.

The first step is a complete inventory: every prescription, every over-the-counter product, every supplement, with doses and who prescribed them.

Each item is then assessed against current goals. A drug started for a condition that resolved, or one whose benefit is long-term while the person's horizon is short, is a candidate.

Tapering is planned rather than abrupt for anything with withdrawal risk, and several classes — sedatives among them — require slow reduction over weeks to months.

One change at a time is the rule, with a defined interval before the next, so that any effect can be attributed.

Informants matter throughout. A family member's account of function at home — managing money, medications, appointments — is more informative than any single office test, and clinicians ask for it explicitly where consent allows.

Monitoring closes the loop. Symptoms, cognition and function are checked at the follow-up, and a change that made things worse is reversed rather than endured.

The scale of the problem is worth stating in proportion. Reviews consistently find that a meaningful minority of older adults take at least one medicine flagged by the published criteria, which is large enough to matter and far from an epidemic of misdiagnosis.

Documentation closes the loop for the family as much as for the clinician. A written note of what was changed, when and why travels with the person to the next appointment, which matters most where several prescribers are involved and none of them sees the whole list.

The composite point is that medication effects on cognition are established, cumulative and reversible, that published criteria and burden scales exist to identify them, and that the step which actually helps is a structured review with the prescriber rather than a list of drugs to be frightened of.